Dyslipoproteinemia in Gestosis in Early Puerperium
https://doi.org/10.15360/1813-9779-2008-5-31
Abstract
Objective: to study the blood atherogenic potential in women with gestosis in early puerperium to assess a risk of cardiovascular diseases. Subjects and methods: The concentrations of triglycerides, total cholesterol, and cholesterols of high-density lipoprotein, low-density lipoprotein, and very low-density lipoprotein were measured in 32 patients aged 25—30 years in early puerperium. The data of examining women with gestoses (Group 3) were compared with the results of examining those after physiological pregnancy delivered both during vaginal delivery (Group 1) and via cesarean section (Group 2). Results and discussion. The puerperas with gestosis had significant hypertriglyceridemia and hyperbetacholesterolemia throughout the follow-up. There were no significant abnormal concentrations of low-density lipoproteins. In gestosis and after cesarean section, there was an almost double fall in the blood concentration of high-density lipoproteins to the level that assigned these patients to a group at risk for cardiovascular diseases. In these patients, the cholesterol atherogenicity coefficient was drastically increased. A moderate increase in the blood atherogenic potential in early puerperium was noted both during normal pregnancy and at normal labor. Conclusion. Concomitance of hypertriglyceridemia and hyperprebetacholesrerolemia with the low concentration of high-density lipoproteins suggests that after prior gestosis, cardiovascular complications may develop, presenting a high death risk. It is concluded that it is necessary to monitor the blood lipoprotein spectrum during gestation and puerperium and atherogenic dyslipoproteinemia can be corrected in case of its detection. Key words: gestosis, puerperium, dyslipoproteinemia, hypertriglyceridemia, hyperprebetacholesterolemia.
References
1. Савельева Г. М., Шалина Ф. И.
2. Мишина И. Е.Клиническое и прогностическое значение нейровеге-тативных и метаболических нарушений при артериальной гипер-тензии у беременных: автореф. дис. … д-ра мед. наук. Иваново; 2007.
3. Медвинский И. Д., Юрченко Л. Н., Пестряева Л. А. и соавт.Современная концепция полиорганной недостаточности при гестозе. Перинатальная анестезиология и интенсивная терапия матери и новорожденного. Екатеринбург; 1999. 25—32.
4. Кантемирова З. Р., Петухов В. А.Беременность, желчный пузырь и липидный дистресс-синдром: диагностика и принципы лечения. Гинекология 2005; 7 (2): 76—79.
5. Серов В. Н.Акушерская патология и синдром системного воспалительного ответа. Рус. мед. журн. 2004; 12 (13): 741—742.
6. Fernandez-Real J. M., Guttieruez C., Ricard W. et al.Plasma levels of soluble fraction of tumor necrosis factor receptors 1 and 2 are independent determinants of plasma cholesterol and LDL-cholesterol concentrations in healthy subject. Atherosclerosis 1999; 146 (2): 321—327.
7. De Caterina R., Manes C.Inflammation in early atherogenesis: impact of ACE inhibition. Eur. Heart. J. 2002; 5 (Suppl. A): 15—24.
8. ThieleJ. G, Niezen-Koning K. E., van Gennip A. H. et al.Increased plasma carnitine concentration in preeclamsia. Obstet. Gynecol. 2004; 103 (5 Pt. 1): 876-880.
9. Титов В. Н.Фундаментальная медицина. Единение физической химии, методических подходов общей биологии и медицины в выяснении этиологии и патогенеза заболеваний человека. Клинич. лаб. диагностика 2005; 1: 3—7.
10. Титов В. Н., Осипов С. Г.Атеросклероз. Роль эндогенного воспаления, белков острой фазы и жирных кислот. М.; 2003.
11. Талаева Т. В., Братусь В. В.Системное воспаление как причина нарушений обмена липопротеинов и развития инсулинорезистентно-сти. Укр. кардиол. журн. 2001; 6: 69—74.
12. Юрченко Л. Н., Черешнев В. А., Гусев Е. Ю. и ^ает.Системное воспаление и система гемостаза в акушерской патологии. Екатеринбург; 2004.
13. Константинова Е. В.Реологические свойства крови у больных ишемической болезнью сердца при различных формах дислипо-протеинемии. В кн.: Материалы Междунар. конф. по гемореологии. Ярославль; 2001. 73.
14. Cominachini L., Garbin U., Pasini A. F. et al.Oxidised low-density lipoprotein increases the production of intracellular reactive oxygen species in endothelial cells inhibitory effect of lacidipine. J. Hypertension 1998; 16: 1913—1919.
15. Kopprasch S., PietschJ., Kulisch E. et al. In vivoevidence oxidation of circulating LDL in impaired glucose tolerance. Diabetes 2002; 51: 3102—3106.
16. Natarajan R., NadlerJ. L.Lipid inflammatory mediators in diabetic vascular disease. Arterioscl. Thromb. Vasc. Biol. 2004; 24: 1542—1548.
17. Manolio T. A., Pearson T. A., Wenger N. K. et al.Cholesterol and heart disease in older persons and women. Rewiew of an NHLBI Workshop. Ann. Epidemiol.1992; 2: 161—176.
18. Bass K. M., Newschaffer C. J., Klag M. J., Bush T. L.Plasma lipoprotein levels as predictors cardiovascular death in women. Arch. Intern. Med. 1993; 153: 2209—2216.
19. La Rose J. C.TYs and coronary risk in women and elderly. Arch. Intern. Med. 1997; 157: 961—968.
Review
For citations:
Shcherbakova L.N., Nazarov B.F., Molchanova L.V. Dyslipoproteinemia in Gestosis in Early Puerperium . General Reanimatology. 2008;4(5):31. (In Russ.) https://doi.org/10.15360/1813-9779-2008-5-31
Views:
1018
Email this article 